SLS
Sellas Life Sciences Group Inc
NASDAQ: SLS · HEALTHCARE · BIOTECHNOLOGY
$4.95
+6.00% today
Updated 2026-04-30
Market cap
$900.52M
P/E ratio
—
P/S ratio
26.90x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$1 – $6
Volume
6.7M
Sellas Life Sciences Group Inc (SLS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0.00 | $2.04M | $2.49M | $9.32M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1900.00 | $7.60M | $1.00M | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | +22.0% | +274.7% | -100.0% | — | — | — | — | — | +399900.0% | -86.8% | -100.0% | — | — |
| Cost of revenue | — | $11.41M | — | — | — | $163000.00 | $49000.00 | $520000.00 | $1.40M | $355000.00 | $3000.00 | $0.00 | $0.00 | — | $377000.00 | $200000.00 | $100000.00 | $0.00 | — | — |
| Gross profit | — | $-11.41M | — | — | — | $-20.79M | $2.04M | $1.97M | $7.92M | $-355000.00 | $-3000.00 | $0.00 | $0.00 | — | $1900.00 | $7.40M | $900000.00 | $0.00 | — | — |
| Gross margin | — | — | — | — | — | — | 100.0% | 79.1% | 84.9% | — | — | — | — | — | 100.0% | 97.4% | 90.0% | — | — | — |
| R&D | $1.30M | $6.75M | $7.05M | $8.89M | $7.87M | $11.54M | $14.61M | $21.08M | $28.35M | $23.61M | $19.86M | $6.07M | $18.32M | $10.12M | $9.28M | $21.37M | $30.27M | $24.01M | $19.10M | $16.02M |
| SG&A | — | $3.73M | $4.87M | $5.48M | $8.75M | $6.86M | $6.58M | $14.60M | $31.34M | $10.61M | $12.01M | $15.09M | $12.77M | $9.92M | $9.60M | $11.32M | $12.58M | $13.86M | $12.42M | $12.25M |
| Operating income | $-2.40M | $-11.41M | $-14.55M | $-17.52M | $-16.63M | $-20.79M | $-21.20M | $-33.84M | $-36.61M | $-34.22M | $-15.99M | $-15.71M | $-31.59M | $-20.04M | $-16.98M | $-25.29M | $-41.95M | $-37.87M | $-31.51M | $-28.27M |
| Operating margin | — | — | — | — | — | — | -1040.2% | -1360.7% | -392.8% | — | — | — | — | — | -893789.5% | -332.8% | -4195.0% | — | — | — |
| EBITDA | $-2.40M | $-10.93M | $-14.24M | $-18.22M | $-11.82M | $-11.32M | $-21.15M | $7.63M | $-36.61M | $-37.48M | $-15.98M | $-23.04M | $-33.40M | $668000.00 | $26.52M | $-18.32M | $-31.49M | $529000.00 | $632000.00 | $-28.27M |
| EBITDA margin | — | — | — | — | — | — | -1037.8% | 306.7% | -392.8% | — | — | — | — | — | 1396015.8% | -241.1% | -3149.3% | — | — | — |
| EBIT | $-2.40M | $-10.96M | $-14.37M | $-18.38M | $-11.99M | $-11.48M | $-21.20M | $7.18M | $-37.05M | $-37.83M | $-15.99M | $-23.04M | $-35.70M | $-16.54M | $-16.76M | $-19.59M | $-31.95M | $-37.34M | $-30.88M | — |
| Interest expense | $0.00 | $0.00 | $0.00 | $5000.00 | $5000.00 | $0.00 | $33000.00 | $807000.00 | $1.11M | $760000.00 | $3.51M | $462000.00 | $266000.00 | $118000.00 | $390000.00 | $4.36M | $649000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2.40M | $-10.99M | $-14.37M | $-18.39M | $-11.99M | $-11.48M | $-34.97M | $-76.68M | $-36.61M | $-63.90M | $-23.55M | $-23.75M | $-27.67M | $-19.29M | $-16.76M | $-20.70M | $-41.30M | $-37.34M | $-30.88M | $-26.86M |
| Net income growth (YoY) | — | -357.0% | -30.8% | -27.9% | +34.8% | +4.2% | -204.5% | -119.3% | +52.3% | -74.6% | +63.1% | -0.9% | -16.5% | +30.3% | +13.1% | -23.5% | -99.5% | +9.6% | +17.3% | +13.0% |
| Profit margin | — | — | — | — | — | — | -1715.8% | -3083.2% | -392.8% | — | — | — | — | — | -881947.4% | -272.4% | -4130.1% | — | — | — |